These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29096681)

  • 1. SlowMo, a digital therapy targeting reasoning in paranoia, versus treatment as usual in the treatment of people who fear harm from others: study protocol for a randomised controlled trial.
    Garety PA; Ward T; Freeman D; Fowler D; Emsley R; Dunn G; Kuipers E; Bebbington P; Waller H; Greenwood K; Rus-Calafell M; McGourty A; Hardy A
    Trials; 2017 Nov; 18(1):510. PubMed ID: 29096681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis: A Randomized Clinical Trial.
    Garety P; Ward T; Emsley R; Greenwood K; Freeman D; Fowler D; Kuipers E; Bebbington P; Rus-Calafell M; McGourty A; Sacadura C; Collett N; James K; Hardy A
    JAMA Psychiatry; 2021 Jul; 78(7):714-725. PubMed ID: 33825827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Inclusive, User-Centered Design Research Can Improve Psychological Therapies for Psychosis: Development of SlowMo.
    Hardy A; Wojdecka A; West J; Matthews E; Golby C; Ward T; Lopez ND; Freeman D; Waller H; Kuipers E; Bebbington P; Fowler D; Emsley R; Dunn G; Garety P
    JMIR Ment Health; 2018 Dec; 5(4):e11222. PubMed ID: 30518514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of a new translational treatment for persecutory delusions: study protocol for a randomised controlled trial (The Feeling Safe Study).
    Freeman D; Waite F; Emsley R; Kingdon D; Davies L; Fitzpatrick R; Dunn G
    Trials; 2016 Mar; 17(1):134. PubMed ID: 26969128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Bias Modification for paranoia (CBM-pa): study protocol for a randomised controlled trial.
    Yiend J; Trotta A; Meek C; Dzafic I; Baldus N; Crane B; Kabir T; Stahl D; Heslin M; Shergill S; McGuire P; Peters E
    Trials; 2017 Jun; 18(1):298. PubMed ID: 28662715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SlowMo therapy, a new digital blended therapy for fear of harm from others: An account of therapy personalisation within a targeted intervention.
    Ward T; Hardy A; Holm R; Collett N; Rus-Calafell M; Sacadura C; McGourty A; Vella C; East A; Rea M; Harding H; Emsley R; Greenwood K; Freeman D; Fowler D; Kuipers E; Bebbington P; Garety P
    Psychol Psychother; 2022 Jun; 95(2):423-446. PubMed ID: 35019210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging the Digital Divide in Psychological Therapies: Observational Study of Engagement With the SlowMo Mobile App for Paranoia in Psychosis.
    Hardy A; Ward T; Emsley R; Greenwood K; Freeman D; Fowler D; Kuipers E; Bebbington P; Garety P
    JMIR Hum Factors; 2022 Jul; 9(3):e29725. PubMed ID: 35776506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thinking Well: A randomised controlled feasibility study of a new CBT therapy targeting reasoning biases in people with distressing persecutory delusional beliefs.
    Waller H; Emsley R; Freeman D; Bebbington P; Dunn G; Fowler D; Hardy A; Kuipers E; Garety P
    J Behav Ther Exp Psychiatry; 2015 Sep; 48():82-9. PubMed ID: 25770671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. User-Centered Development of STOP (Successful Treatment for Paranoia): Material Development and Usability Testing for a Digital Therapeutic for Paranoia.
    Hsu CW; Stahl D; Mouchlianitis E; Peters E; Vamvakas G; Keppens J; Watson M; Schmidt N; Jacobsen P; McGuire P; Shergill S; Kabir T; Hirani T; Yang Z; Yiend J
    JMIR Hum Factors; 2023 Dec; 10():e45453. PubMed ID: 38064256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson's disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014).
    Lakshminarayana R; Wang D; Burn D; Chaudhuri KR; Cummins G; Galtrey C; Hellman B; Pal S; Stamford J; Steiger M; Williams A;
    Trials; 2014 Sep; 15():374. PubMed ID: 25257518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The service user experience of SlowMo therapy: A co-produced thematic analysis of service users' subjective experience.
    Greenwood KE; Gurnani M; Ward T; Vogel E; Vella C; McGourty A; Robertson S; Sacadura C; Hardy A; Rus-Calafell M; Collett N; Emsley R; Freeman D; Fowler D; Kuipers E; Bebbington P; Dunn G; Michelson D; Garety P;
    Psychol Psychother; 2022 Sep; 95(3):680-700. PubMed ID: 35445520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive mechanisms of change in delusions: an experimental investigation targeting reasoning to effect change in paranoia.
    Garety P; Waller H; Emsley R; Jolley S; Kuipers E; Bebbington P; Dunn G; Fowler D; Hardy A; Freeman D
    Schizophr Bull; 2015 Mar; 41(2):400-10. PubMed ID: 25053650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persecutory delusions: effects of Cognitive Bias Modification for Interpretation and the Maudsley Review Training Programme on social anxiety, jumping to conclusions, belief inflexibility and paranoia.
    Hurley J; Hodgekins J; Coker S; Fowler D
    J Behav Ther Exp Psychiatry; 2018 Dec; 61():14-23. PubMed ID: 29883776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analyses.
    Freeman D; Lister R; Waite F; Galal U; Yu LM; Lambe S; Beckley A; Bold E; Jenner L; Diamond R; Kirkham M; Twivy E; Causier C; Carr L; Saidel S; Day R; Beacco A; Rovira A; Ivins A; Nah R; Slater M; Clark DM; Rosebrock L
    Lancet Psychiatry; 2023 Nov; 10(11):836-847. PubMed ID: 37742702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated psychological therapy using virtual reality (VR) for patients with persecutory delusions: study protocol for a single-blind parallel-group randomised controlled trial (THRIVE).
    Freeman D; Lister R; Waite F; Yu LM; Slater M; Dunn G; Clark D
    Trials; 2019 Jan; 20(1):87. PubMed ID: 30696471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological Support for Personality (PSP) versus treatment as usual: study protocol for a feasibility randomized controlled trial of a low intensity intervention for people with personality disorder.
    Crawford MJ; Thana L; Parker J; Turner O; Xing KP; McMurran M; Moran P; Weaver T; Barrett B; Claringbold A; Bassett P; Sanatinia R
    Trials; 2018 Oct; 19(1):547. PubMed ID: 30305148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trial.
    Garety P; Edwards CJ; Ward T; Emsley R; Huckvale M; McCrone P; Rus-Calafell M; Fornells-Ambrojo M; Gumley A; Haddock G; Bucci S; McLeod H; Hardy A; Peters E; Myin-Germeys I; Craig T
    Trials; 2021 May; 22(1):366. PubMed ID: 34034792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial.
    Giosan C; Cobeanu O; Mogoaşe C; Szentagotai A; Mureşan V; Boian R
    Trials; 2017 May; 18(1):215. PubMed ID: 28494802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internet-based self-help therapy with FearFighter™ versus no intervention for anxiety disorders in adults: study protocol for a randomised controlled trial.
    Fenger M; Lindschou J; Gluud C; Winkel P; Jørgensen L; Kruse-Blinkenberg S; Lau M
    Trials; 2016 Oct; 17(1):525. PubMed ID: 27793181
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.